RENEE BROWN: Open Payments
NPI 1912371782 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,135 in 68 payments from 22 companies in 2025. Trend: 2023 $1,698 · 2024 $2,311 · 2025 $2,135
Food & beverage: $2,040Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $282 |
| Madrigal Pharmaceuticals | 4 | $280 |
| Janssen Biotech, Inc. | 4 | $232 |
| PFIZER INC. | 9 | $149 |
| Regeneron Healthcare Solutions, Inc. | 2 | $147 |
| Enterra Medical, Inc. | 1 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $118 |
| Phathom Pharmaceuticals, Inc. | 8 | $116 |
| Gilead Sciences, Inc. | 1 | $113 |
| Mallinckrodt Hospital Products Inc. | 1 | $110 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, VELSIPITY, VOQUEZNA, Livdelzi, TERLIVAZ, ZENPEP.
Industry payments across GA — which companies pay providers there.
